YahooAugust 7, 2026 at 2:22 PM NY28 days ago
CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong
CYTK tops Q2 revenue estimates as Myqorzo gains traction, but higher launch costs and the absence of milestone payments weigh on results.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo
Companies in This Story
Related Stories
Which dow jones stocks are moving on Friday?
ChartMill3 hours ago
Exploring the top movers within the S&P500 index during today's session.
ChartMill3 hours ago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo3 hours ago
Sector Update: Financial
Yahoo5 hours ago
Should You Buy, Sell or Hold PVH Stock Post Q2 Earnings?
Yahoo5 hours ago